REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire’s partner Brandon Walker is urging Regeneron (REGN) investors who claim losses to contact him to discuss potential legal options. The announcement signals ongoing shareholder litigation risk but provides no financial figures, so near-term market impact is likely limited.